CAS No.11111-23-2,Lividomycin Suppliers

CAS No.:	11111-23-2
Name:	Lividomycin
Molecular Structure:

Formula:	N/A
Safety:	Poison by intravenous route. Moderately toxic by subcutaneous and intramuscular routes. An experimental teratogen. Experimental reproductive effects.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 11111-23-2

Chemistry

IUPAC Name:  (2R,3S,4S,5S,6R)-2-[(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-4-hydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-
3,4,5-triol
Synonyms of Lividomycin (CAS NO.11111-23-2) : (1R,2R,3S,4R,6S)-4,6-Diamino-3-hydroxy-2-{[alpha-D-mannopyranosyl-(1->4)-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy}cyclohexyl 2-amino-2,3-dideoxy-alpha-D-ribo-hexopyr ; alpha-D-Ribo-hexopyranoside, (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-[[O-alpha-D-mannopyranosyl-(1->4)-O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy]cyclohexyl 2-amino-2,3-dideoxy- ; Anoside ; Antibiotic SF 767A
InChI:InChI=1/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1
CAS NO:11111-23-2
Molecular Formula:C₂₉H₅₅N₅O₁₈
Molecular Weight :761.7697
Molecular Structure :
Index of Refraction: 1.675
Surface Tension: 106.8 dyne/cm
Density: 1.65 g/cm³
Flash Point: 599.8 °C
Enthalpy of Vaporization: 177.12 kJ/mol
Boiling Point: 1068.2 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intramuscular	1348mg/kg (1348mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
mouse	LD50	intravenous	225mg/kg (225mg/kg)	SENSE ORGANS AND SPECIAL SENSES: "RETINAL CHANGES (PIGMENTARY DEPOSITIONS, RETINITIS, OTHER): EYE" BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
mouse	LD50	oral	> 10gm/kg (10000mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
mouse	LD50	subcutaneous	1249mg/kg (1249mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
rat	LD50	intramuscular	1750mg/kg (1750mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
rat	LD50	intravenous	365mg/kg (365mg/kg)	BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
rat	LD50	oral	> 10gm/kg (10000mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.
rat	LD50	subcutaneous	1819mg/kg (1819mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972.